[1]
Ashvini Pawar et al. 2026. LC–MS/MS Bioanalysis of Gabapentin in Human Plasma: Method Development, Validation, and Regulatory Perspectives under USFDA and ICH M10 Guidelines. Asian Journal of Pharmaceutical Research and Development. 14, 2 (Apr. 2026), 06–16. DOI:https://doi.org/10.22270/ajprd.v14i2.1712.